CRSP
Price
$45.75Alerts
Change
+$0.60 (+1.33%)
Updated
Nov 11 closing price
Capitalization
4.84B
96 days until earnings call
Intraday BUY SELL Signals
VERU
Price
$2.14Alerts
Change
+$0.02 (+0.94%)
Updated
Nov 11 closing price
Capitalization
36.15M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRSP vs VERU

CRSP vs VERU Comparison Chart in %
View a ticker or compare two or three
VS
CRSP vs. VERU commentary
Nov 12, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRSP is a StrongBuy and VERU is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CRSP with price predictions
Nov 11, 2026

CRSP's Stochastic Oscillator is sitting in oversold zone for 4 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +5.42% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRSP advanced for three days, in 210 of 257 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

CRSP may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRSP as a result. In 79 of 98 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 81%.

The Moving Average Convergence Divergence Histogram (MACD) for CRSP turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 38 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 79%.

The 10-day moving average for CRSP crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRSP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

The Aroon Indicator for CRSP entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 24 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.772) is normal, around the industry mean (3.498). P/E Ratio (-10.631) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (454.545) is also within normal values, averaging (440.869).

The Tickeron PE Growth Rating for this company is 54 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 72 (best 1 - 100 worst), indicating slightly worse than average price growth. CRSP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRSP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

A.I.Advisor
a Summary for VERU with price predictions
Nov 11, 2026

VERU sees its Stochastic Oscillator ascending out of oversold territory

On November 10, 2026, the Stochastic Oscillator for VERU moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 70 instances where the indicator left the oversold zone. In 62 of the 70 cases the stock moved higher in the following days. This puts the odds of a move higher at over 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where VERU's RSI Oscillator exited the oversold zone, 23 of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

Following a +6.31% 3-day Advance, the price is estimated to grow further. Considering data from situations where VERU advanced for three days, in 205 of 248 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

VERU may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VERU as a result. In 87 of 93 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The Moving Average Convergence Divergence Histogram (MACD) for VERU turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In 38 of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

The 10-day moving average for VERU crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

The 50-day moving average for VERU moved below the 200-day moving average on October 26, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VERU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.

The Aroon Indicator for VERU entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. VERU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.274) is normal, around the industry mean (3.498). P/E Ratio (-3.655) is within average values for comparable stocks, (-1.193). VERU's Projected Growth (PEG Ratio) (421.660) is very high in comparison to the industry average of (9.059). Dividend Yield (0.132) settles around the average of (130.981) among similar stocks. P/S Ratio (1.966) is also within normal values, averaging (440.869).

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VERU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
CRSP vs VERU: Fundamental Ratings
CRSP
VERU
OUTLOOK RATING
1..100
1814
VALUATION
overvalued / fair valued / undervalued
1..100
24
Undervalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9698
PRICE GROWTH RATING
1..100
7263
P/E GROWTH RATING
1..100
54100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRSP's Valuation (24) in the Biotechnology industry is significantly better than the same rating for VERU (98) in the Household Or Personal Care industry. This means that CRSP’s stock grew significantly faster than VERU’s over the last 12 months.

CRSP's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as VERU (100) in the Household Or Personal Care industry. This means that CRSP’s stock grew similarly to VERU’s over the last 12 months.

CRSP's SMR Rating (96) in the Biotechnology industry is in the same range as VERU (98) in the Household Or Personal Care industry. This means that CRSP’s stock grew similarly to VERU’s over the last 12 months.

VERU's Price Growth Rating (63) in the Household Or Personal Care industry is in the same range as CRSP (72) in the Biotechnology industry. This means that VERU’s stock grew similarly to CRSP’s over the last 12 months.

CRSP's P/E Growth Rating (54) in the Biotechnology industry is somewhat better than the same rating for VERU (100) in the Household Or Personal Care industry. This means that CRSP’s stock grew somewhat faster than VERU’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRSPVERU
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 14 days ago
82%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
84%
Aroon
ODDS (%)
Bearish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
COMPARISON
Comparison
Nov 12, 2026
Stock price -- (CRSP: $45.75 vs. VERU: $2.12)
Brand notoriety: CRSP and VERU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRSP: 191% vs. VERU: 70%
Market capitalization -- CRSP: $4.84B vs. VERU: $36.15M
CRSP [@Biotechnology] is valued at $4.84B. VERU’s [@Biotechnology] market capitalization is $36.15M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRSP’s FA Score shows that 1 FA rating(s) are green while VERU’s FA Score has 0 green FA rating(s).

  • CRSP’s FA Score: 1 green, 4 red.
  • VERU’s FA Score: 0 green, 5 red.
According to our system of comparison, CRSP is a better buy in the long-term than VERU.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRSP’s TA Score shows that 3 TA indicator(s) are bullish while VERU’s TA Score has 4 bullish TA indicator(s).

  • CRSP’s TA Score: 3 bullish, 5 bearish.
  • VERU’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than VERU.

Price Growth

CRSP (@Biotechnology) experienced а -11.64% price change this week, while VERU (@Biotechnology) price change was -1.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.

Reported Earning Dates

CRSP is expected to report earnings on Feb 16, 2027.

VERU is expected to report earnings on Dec 16, 2026.

Industries' Descriptions

@Biotechnology (-0.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with BEAM. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
+1.33%
BEAM - CRSP
77%
Closely correlated
+2.62%
NTLA - CRSP
72%
Closely correlated
+2.15%
PRME - CRSP
66%
Loosely correlated
+10.26%
RXRX - CRSP
65%
Loosely correlated
+1.13%
EDIT - CRSP
63%
Loosely correlated
-4.99%
More

VERU and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with INDP. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then INDP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
+0.94%
INDP - VERU
48%
Loosely correlated
+10.69%
ABCL - VERU
40%
Loosely correlated
-4.09%
RXRX - VERU
38%
Loosely correlated
+1.13%
CRSP - VERU
36%
Loosely correlated
+1.33%
PRAX - VERU
35%
Loosely correlated
+2.55%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BIBL53.571.09
+2.08%
Inspire 100 ETF (BIBL)
SPUS57.741.05
+1.85%
SP Funds S&P 500 Sharia Industry Exclusions ETF (SPUS)
SQLV53.060.18
+0.33%
Royce Quant Small-Cap Quality Value ETF (SQLV)
BUFI42.120.07
+0.15%
AB International Buffer ETF Intl Buffer ETF (BUFI)
RESM23.55N/A
N/A
Columbia Research Enhanced Small Cap ETF (RESM)